Business Standard

Chinese Covid-19 vaccine expected to begin mass output this year: Report

The vaccine, jointly developed by the Beijing Institute of Biological Products and China National Biotec Group Co., has completed phase II testing

testing, private laboratories, labs, vaccines, doctors, nurses, health, coronavirus
Premium

President Xi Jinping has promised to share any successful vaccine globally, but Chinese companies still face challenges

Bloomberg
A front-running Covid-19 vaccine candidate being developed in China is expected to be available as soon as the end of this year, according to a report published in the official Wechat account of the State-owned Assets Supervision and Administration Commission.

The vaccine, jointly developed by the Beijing Institute of Biological Products and China National Biotec Group Co., has completed phase II testing and may be ready for the market at the end of this year or early next year, said the report.

The production line for the vaccine will be fully disinfected and closed in preparation for output to start Saturday, and

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 30 2020 | 8:28 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com